Regulatory Basis for Exemption
The company states that it qualifies for exemption under Regulation 15(2)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This exemption applies because the company's equity shares are listed on the SME Platform of BSE Limited, making the corporate governance provisions under Regulation 27(2) of SEBI (LODR) Regulations, 2015 not applicable.
Supporting Documentation
The filing includes a certificate from HPN & Associates, Company Secretaries, dated 10 July 2026, which confirms the non-applicability of corporate governance provisions. The certificate specifically references that Regulations 17, 17A, 18, 19, 20, 21, 22, 24, 24A, 25, 26, 27 and certain clauses of Regulation 46 and Schedule V do not apply to entities listed on SME Exchanges.
Effective Period
The exemption applies specifically for the quarter ended 30 June 2026.
#Tags: #MahamayaLifesciences #SEBILODR #CorporateGovernance #RegulatoryCompliance #SMEListing